EZH2 and hepatocellular carcinoma: Firstly, we detected cell viability following transfected with miR-138 mimic, with or without EZH2 plasmid and with cisplatin treatment, indicating that the effect of miR-138 mimic on cis sensitivity was lost when combined with the EZH2 plasmid in HCC cells (Figure 6(a)).